GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LG Life Sciences Ltd (XKRX:068875.PFD) » Definitions » ROE %

LG Life Sciences (XKRX:068875.PFD) ROE % : 7.36% (As of Sep. 2016)


View and export this data going back to 2002. Start your Free Trial

What is LG Life Sciences ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. LG Life Sciences's annualized net income for the quarter that ended in Sep. 2016 was ₩20,545.60 Mil. LG Life Sciences's average Total Stockholders Equity over the quarter that ended in Sep. 2016 was ₩279,084.72 Mil. Therefore, LG Life Sciences's annualized ROE % for the quarter that ended in Sep. 2016 was 7.36%.

The historical rank and industry rank for LG Life Sciences's ROE % or its related term are showing as below:

XKRX:068875.PFD' s ROE % Range Over the Past 10 Years
Min: -1.01   Med: 4.9   Max: 10.38
Current: 10.38

During the past 9 years, LG Life Sciences's highest ROE % was 10.38%. The lowest was -1.01%. And the median was 4.90%.

XKRX:068875.PFD's ROE % is not ranked
in the Biotechnology industry.
Industry Median: -41.51 vs XKRX:068875.PFD: 10.38

LG Life Sciences ROE % Historical Data

The historical data trend for LG Life Sciences's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LG Life Sciences ROE % Chart

LG Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
ROE %
Get a 7-Day Free Trial Premium Member Only 2.35 3.26 1.66 -1.01 4.90

LG Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.79 4.74 18.17 11.31 7.36

Competitive Comparison of LG Life Sciences's ROE %

For the Biotechnology subindustry, LG Life Sciences's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LG Life Sciences's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LG Life Sciences's ROE % distribution charts can be found below:

* The bar in red indicates where LG Life Sciences's ROE % falls into.


;
;

LG Life Sciences ROE % Calculation

LG Life Sciences's annualized ROE % for the fiscal year that ended in Dec. 2015 is calculated as

ROE %=Net Income (A: Dec. 2015 )/( (Total Stockholders Equity (A: Dec. 2014 )+Total Stockholders Equity (A: Dec. 2015 ))/ count )
=12443.782/( (249136.897+258321.529)/ 2 )
=12443.782/253729.213
=4.90 %

LG Life Sciences's annualized ROE % for the quarter that ended in Sep. 2016 is calculated as

ROE %=Net Income (Q: Sep. 2016 )/( (Total Stockholders Equity (Q: Jun. 2016 )+Total Stockholders Equity (Q: Sep. 2016 ))/ count )
=20545.6/( (276212.378+281957.07)/ 2 )
=20545.6/279084.724
=7.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2016) net income data. ROE % is displayed in the 30-year financial page.


LG Life Sciences  (XKRX:068875.PFD) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2016 )
=Net Income/Total Stockholders Equity
=20545.6/279084.724
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(20545.6 / 517919.052)*(517919.052 / 814406.6145)*(814406.6145 / 279084.724)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.97 %*0.6359*2.9181
=ROA %*Equity Multiplier
=2.52 %*2.9181
=7.36 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2016 )
=Net Income/Total Stockholders Equity
=20545.6/279084.724
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (20545.6 / 18163.36) * (18163.36 / 38737.46) * (38737.46 / 517919.052) * (517919.052 / 814406.6145) * (814406.6145 / 279084.724)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.1312 * 0.4689 * 7.48 % * 0.6359 * 2.9181
=7.36 %

Note: The net income data used here is four times the quarterly (Sep. 2016) net income data. The Revenue data used here is four times the quarterly (Sep. 2016) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


LG Life Sciences ROE % Related Terms

Thank you for viewing the detailed overview of LG Life Sciences's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


LG Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
LG Life Sciences., Ltd. manufactures and markets medicines and fine chemistry products. The company produces the medicine based on genetic engineering and raw materials for agricultural pesticides and medicines.

LG Life Sciences Headlines

No Headlines